Johannesburg - The Competition Commission announced it will investigate price fixing of cancer medication.
Commissioner Tembinkosi Bonakele was speaking at a briefing at the Department of Trade and Industry headquarters in Pretoria on Tuesday.
The investigation is to be initiated against oncology medicine provider Roche Products, which includes its US-based biotechnology company Genentech Incorporated.
The commission will also investigate Pfizer, for suspected excessive pricing of lung cancer medication in South Africa. Aspen Pharmacare
The commission plans to obtain evidence from patients.
“We have to treat this with the urgency and sensitivity it deserves, there are still many patients in need of these drugs,” said Bonakele.
“We have to look at patents and how they get abused. A perpetual monopoly aided by patents is unlawful,” he said.
This follows a previous report by Fin24 that Aspen is under preliminary investigation for alleged price-fixing.
Aspen is undergoing a legal process with European regulators over allegations that the company secretly planned to destroy life-saving cancer medication European countries to allow price hikes, Fin24 reported.
While we have your attention...
An increasingly rare commodity, quality independent journalism costs money - though not nearly as much as its absence.
Every article, every day, is our contribution to Defending Truth in South Africa. If you would like to join us on this mission, you could do much worse than support Daily Maverick's quest by becoming a Maverick Insider.
Click here to become a Maverick Insider and get a closer look at the Truth.
"Look for lessons about haunting when there are thousands of ghosts; when entire societies become haunted by terrible deeds that are systematically occurring and are simultaneously denied by every public organ of governance and communication." ~ Avery Gordon